Molefy Pharma is a biotech spin off dedicated to pioneering groundbreaking treatments for neurodegenerative diseases. Our mission is to develop a therapy that not only slows but reverses disease progression, bringing real hope to patients and their families.
At Molefy Pharma we are dedicated to developing innovative treatments that offer real hope to patients. Our goal is clear: to create a therapy that not only slows ALS but reverses its devastating effects. Backed by scientific excellence and a deep commitment to those affected, we are determined to make a lasting impact.
We strive to push the boundaries of biotechnology with every step we take, while always keeping the needs of ALS patients at the heart of our work.